Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
In vivo biodistribution of edelfosine-loaded lipid nanoparticles radiolabeled with Technetium-99 m: Comparison of administration routes in mice.
Eur J Pharm Biopharm. 2022 Jun;175:1-6. doi: 10.1016/j.ejpb.2022.04.007. Epub 2022 Apr 21.
Eur J Pharm Biopharm. 2022.
PMID: 35462025
Free article.
Efficacy of edelfosine lipid nanoparticles in breast cancer cells.
Aznar MÁ, Lasa-Saracíbar B, Estella-Hermoso de Mendoza A, Blanco-Prieto MJ.
Aznar MÁ, et al. Among authors: lasa saracibar b.
Int J Pharm. 2013 Oct 1;454(2):720-6. doi: 10.1016/j.ijpharm.2013.04.068. Epub 2013 Apr 30.
Int J Pharm. 2013.
PMID: 23643510
Free article.
Item in Clipboard
In vitro intestinal co-culture cell model to evaluate intestinal absorption of edelfosine lipid nanoparticles.
Lasa-Saracíbar B, Guada M, Sebastián V, Blanco-Prieto MJ.
Lasa-Saracíbar B, et al.
Curr Top Med Chem. 2014;14(9):1124-32. doi: 10.2174/1568026614666140329225340.
Curr Top Med Chem. 2014.
PMID: 24678709
Free article.
Item in Clipboard
Edelfosine lipid nanoparticles overcome multidrug resistance in K-562 leukemia cells by a caspase-independent mechanism.
Aznar MÁ, Lasa-Saracíbar B, Blanco-Prieto MJ.
Aznar MÁ, et al. Among authors: lasa saracibar b.
Mol Pharm. 2014 Aug 4;11(8):2650-8. doi: 10.1021/mp5000696. Epub 2014 Jun 6.
Mol Pharm. 2014.
PMID: 24865362
Free article.
Item in Clipboard
Lipid nanoparticles protect from edelfosine toxicity in vivo.
Lasa-Saracíbar B, Aznar MÁ, Lana H, Aizpún I, Gil AG, Blanco-Prieto MJ.
Lasa-Saracíbar B, et al.
Int J Pharm. 2014 Oct 20;474(1-2):1-5. doi: 10.1016/j.ijpharm.2014.07.053. Epub 2014 Aug 1.
Int J Pharm. 2014.
PMID: 25091376
Item in Clipboard
Lipid nanoparticles for cancer therapy: state of the art and future prospects.
Lasa-Saracibar B, Estella-Hermoso de Mendoza A, Guada M, Dios-Vieitez C, Blanco-Prieto MJ.
Lasa-Saracibar B, et al.
Expert Opin Drug Deliv. 2012 Oct;9(10):1245-61. doi: 10.1517/17425247.2012.717928. Epub 2012 Sep 5.
Expert Opin Drug Deliv. 2012.
PMID: 22950878
Free article.
Review.
Item in Clipboard
Edelfosine lipid nanosystems overcome drug resistance in leukemic cell lines.
Lasa-Saracíbar B, Estella-Hermoso de Mendoza A, Mollinedo F, Odero MD, Blanco-Príeto MJ.
Lasa-Saracíbar B, et al.
Cancer Lett. 2013 Jul 1;334(2):302-10. doi: 10.1016/j.canlet.2013.01.018. Epub 2013 Jan 23.
Cancer Lett. 2013.
PMID: 23353057
Free article.
Item in Clipboard
Lipid nanoparticles enhance the absorption of cyclosporine A through the gastrointestinal barrier: In vitro and in vivo studies.
Guada M, Lasa-Saracíbar B, Lana H, Dios-Viéitez Mdel C, Blanco-Prieto MJ.
Guada M, et al. Among authors: lasa saracibar b.
Int J Pharm. 2016 Mar 16;500(1-2):154-61. doi: 10.1016/j.ijpharm.2016.01.037. Epub 2016 Jan 18.
Int J Pharm. 2016.
PMID: 26794875
Item in Clipboard
Cite
Cite